I’m a researcher at the MRC Biostatistics Unit, University of Cambridge.
I’m interested in many areas across statistics, machine learning, and their interactions. My research focuses on tailored model development, that is targeted model building for a specific task of interest, mostly prediction.
I’m also developing and applying tools leveraging genomics to detect cancer earlier, which will ultimately lead to more personalized treatment for patients. Toward these goals, I draw from a wide range of disciplines, including molecular biology, computational biology, and medical oncology. More specifically, I’m looking at novel ways to incorporate liquid biopsies into the management of cancer. Liquid biopsies - the analysis of tumours using biomarkers circulating in fluids such as the blood - have the potential to change the way cancer is diagnosed, monitored, and treated.